This NDC is on FDA's drug shortage list (posted Apr 2, 2020)
Product Information
MIDAZOLAM HCL 2 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.4200 per ML under NDC 00409230517. Its NADAC has been published 92 times since Nov 28, 2013.
FDA first approved this application on Jul 22, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 mg/mL
Manufacturer
Hospira Inc.NDC
00409230517
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/19/2025
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075857FDA Approved
7/22/2002
TE Code
AP
On Market Since
8/17/2005
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has been published 92 times since Nov 28, 2013, and over the history we have for it it has risen 92.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4200 per ML |
|---|---|
| All-time high | $0.4710 (Jul 10, 2024) |
| All-time low | $0.2185 (Nov 28, 2013) |
| 52-week high | $0.4200 |
| 52-week low | $0.4200 |
| Median price | $0.4200 |
| Average price | $0.4273 |
| Largest weekly change | +115.5% (May 22, 2024) |
| Weeks tracked | 92 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+92.2%
5Y
+92.2%
All
+92.2%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 2 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 2 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.4200 per ML (NDC 00409230517), effective Feb 11, 2026.
How has the price of MIDAZOLAM HCL 2 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has risen 92.2%. It has been tracked across 92 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 2 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for MIDAZOLAM HCL 2 MG/2 ML VIAL has ranged from a low of $0.2185 (Nov 28, 2013) to a high of $0.4710 (Jul 10, 2024), with a median of $0.4200 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 2 MG/2 ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDAZOLAM HCL 1 MG/ML VIAL, is $0.2185 per ML — about 48% below MIDAZOLAM HCL 2 MG/2 ML VIAL.
Who manufactures MIDAZOLAM HCL 2 MG/2 ML VIAL?
MIDAZOLAM HCL 2 MG/2 ML VIAL (NDC 00409230517) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is MIDAZOLAM HCL 2 MG/2 ML VIAL in shortage?
Yes — NDC 00409230517 is currently listed in FDA's drug shortage database (posted Apr 2, 2020).